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[571 ABSTRACT 
A system for and method of detecting and measuring con- 
centrations of an ultrasonically-reflective microsphere con- 
trast agent involving detecting non-linear sum and difference 
beat frequencies produced by the microspheres when two 
impinging signals with non-identical frequencies are com- 
bined by mixing. These beat frequencies can be used for a 
variety of applications such as detecting the presence of and 
measuring the flow rates of biological fluids and industrial 
liquids, including determining the concentration level of 
microspheres in the myocardium. 
11 Claims, 6 Drawing Sheets 
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BEAT FREQUENCY ULTRASONIC 
MICROSPHERE CONTRAST AGENT 
DETECTION SYSTEM 
ORIGIN OF THE INVENTION 
The invention described herein was jointly made by 
cmployces of the United Statcs Government and in the 
pcrformancc of work under a NASA Contract and is subject 
to the provisions of Section 305 of the National Aeronautics 
and Spacc Act of 1958, as amended, Public Law 85-568 (72 
Stat. 435; 42 USC 2457). 
BACKGROUND OF THE INVENTION 
1. Eield of the Invention 
This invention relates generally to ultrasonically-reflec- 
tive microsphere contrast agents for ultrasonic imaging and 
more particularly to the quantitative detection of micro- 
spheres in biological applications. 
2. Description of the Related Art 
Ultrasonically-reflective microsphere contrast agents are 
used in medical ultrasonic imaging to enhance the image 
obtained by increasing the contrast of and outlining the 
anatomic structures being studied, for example the heart (its 
chambers, blood vessels, and tissue). An example of such an 
agent is Albunex, available from Molecular Biosystems, San 
Diego, Calif. Microsphere contrast agents are also used to 
ultrasonically assess adequacy of blood flow (i.e., perfusion) 
to the heart muscle (Le., myocardium). Assessment of per- 
fusion allows determination of the existence or risk of a 
myacardial infarction (Le., a heart attack), in which the heart 
muscle dies because of blockage by plaque of the blood 
vessels supplying it. 
Currently, microsphere contrast agents must be injected 
directly into the arteries of the heart muscle in order to be 
dctectable with conventional ultrasonic scanners (via video 
intensity) and to thereby allow assessment of myacardial 
perfusion. Consequently, this technique is available only 
during cardiac surgery or catheterization. Non-invasive pro- 
cedures such as peripheral intraveneous injection of the 
microspheres are desirable. However, dilutional effects and 
trapping of the larger, more reflective microspheres by the 
lung circulation lowers the effective microsphere concen- 
tration to such a degree that conventional ultrasonic scanners 
can no longer detect them in the myacardium. 
Monaghan (U.S. Pat. No. 5,255,683) discloses a method 
of microsphere detection based on a shift in the radiofre- 
quency (RF) spectrum of the ultrasonic myocardial echo 
when microspheres are present. This method is used to 
assess myocardial perfusion in patients. This spectral shift 
method does not involve the mixing of two frequencies by 
the microspheres with a subsequent emission of a third 
frequency by the microspheres. The method disclosed by 
Monaghan is only a qualitative detector of microsphere 
prescnce or absence. It does not allow quantitative estima- 
tion of thc microsphere level in the myocardium and thus has 
limited usc in assessing myocardial perfusion. 
Shropc et al. in Ultrasonic Imaging 14(2), April 1992, 
investigated a method of detection based on generation by 
the microspheres of an RF second harmonic of the trans- 
mitted scanner frequency. As the second harmonic generated 
by the myocardium is of much lower magnitude, presence of 
the harmonic correlates with presence of the microspheres. 
Microsphere level in the myocardium per unit time can thus 
bc measured and myocardial pcrfusion derived. The second 
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harmonic detection method, however, requires that the 
microspheres have a fairly specific shell type, and will 
currently work only with specific agents such as SHU508 
(available from the Schering Corp. in Germany). 
Albert (U.S. Pat. No. 4,608,993) discloses measuring 
blood flow using the Doppler shift of ultrasound by blood 
components in a blood vessel. However, this non-invasive 
technique does not use microsphere contrast agents. 
2 
SUMMARY OF THE INVENTION 
In accordance with one aspect of the present invention, a 
method and system for ultrasonically examining tissue using 
an ultrasonically-reflective microsphere contrast agent 
detects the presence of ultrasonic beat frequencies generated 
by the presence of the microspheres. 
More specifically, in accordance with this aspect of the 
present invention, a method of examining tissue using 
ultrasonically-reflective microsphere contrast agents detects 
non-linear sum and difference beat frequency signals which 
are produced when two signals with non-identical frequen- 
cies are combined by mixing. The amplitude of these beat 
frequencies is used to determine the concentration level of 
the microspheres in the myocardium. In the myocardium, 
the microspheres act as non-linear ultrasonic mixers when 
impinged upon by two or more ultrasonic waves of different 
frequencies. The microspheres re-radiate both the impinging 
frequencies, but in addition they generate non-linear differ- 
ence and sum frequencies. This non-linear effect is signifi- 
cantly greater when one or both impinging frequencies 
approximates the resonant frequency of the microspheres. 
Myocardial tissue, on the other hand, reflects the two 
original frequencies since the myocardium does not generate 
substantial amplitudes of sum or difference frequencies. 
To produce the beat frequencies, an insonifier transducer 
instills ultrasonic energy into a patient’s chest at a prescise 
single frequency, ideally the resonant frequency of the 
microspheres. A scanner transducer also instills ultrasonic 
energy into the patient’s chest at a single frequency, but the 
scanner frequency is different than that of the insonifier. In 
addition, the scanner receives and processes the ultrasonic 
echo and generates a video image. The beat frequency signal 
due to the microspheres in the myocardial region of interest 
is detected within the overall echo signal. A plot is then 
generated of the microsphere signal level vs. time, which in 
turn correlates with myocardial perfusion. Myocardial per- 
fusion parameters are derived such as: time to peak of curve, 
time to half peak (ascending and descending portions of 
curve), half-time point slopes, time of appearance of contrast 
agent, and area under the curve. 
The present invention permits the detection of the rela- 
tively small level of microspheres passing through the 
myocardium per unit of time after peripheral intraveneous 
injection. In addition, the present invention derives myocar- 
dial perfusion parameters from this data. Advantages of the 
present invention include both the ability to quantitatively 
detect small levels of microspheres in heart tissue and the 
ability to use this method with all types of microsphere and 
microbubble contrast agents. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a block diagram of one embodiment of the 
present invention in which myocardial perfusion is mea- 
sured; 
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FIG. 2 is a typical plot of difference frequency signal 
amplitude versus time for Albunex microspheres passing 
through a body tissue circulation area such as the myocar- 
dium; 
FIG. 3 is a plot of difference frequency signal amplitude 5 
versus insonifying frequency for Albunex microspheres; 
FIG. 4 is a graphical example of the generation of sum and 
difference signals by the microspheres; 
FIG. 5 is a pair of scan lines showing the region analyzed 1o 
corresponding to the region of interest in the myocardium; 
and 
FIG. 6 is a block diagram of an embodiment of the present 
invention, including the summing circuit, with a generic 
interactive volume. 
detected within the overall echo signal. A plot is then 
generated of the microsphere signal level vs. time, which in 
turn correlates with myocardial perfusion. 
A computer 100 controls the operation of the system, plots 
microsphere concentration vs. time, and derives myocardial 
p e r h i o n  parameters. Such perfusion parameters would 
include: time to peak of curve, time to half peak (ascending 
and descending portions of curve), half-time point slopes, 
time of appearance of contrast agent, and area under the 
curve. FIG. 2 illustrates a typical frequency amplitude 
versus time curve from which perfusion parameters can be 
derived. 
The present invention uses ultrasonic beat frequencies 
generated by the injected microspheres 95 to detect their 
presence and concentration level in the myocardium 98. l5 
DESCRIPTION OF THE PREFERRED 
EMBODIMENTS 
Beat frequencies are produced when two signals with non- 
identical frequencies are combined by mixing. Non-linear 
sum and difference frequencies result, according to the 
Referring to FIG. 1, the insonifier transducer 10 instills 2o followi% trignometric identity: 
ultrasonic energy into a patient's chest 15 at the resonant 
frequency of the microsphere contrast agent, e.g., 1.3 MHz 
for Albunex. The term microsphere as used in this specifi- Cos(A)Cos(B)=%Cos(A+B)+%Cos(A-B) 
cation should be understood to include the Use Of 
microbubbles. The insonifying 
signal generator 20, is amp1ified by the RF power amp1ifier 
30, and is then fed to the insonifying transducer lo. The 
Referring to FIGS, 3 and 4, in the myocx~ium 98, the 
Originates from a 25 microspheres 95 act as non-linear ultrasonic mixers when 
impinged upon by two or more ultrasonic waves of different 
frequencies, The microspheres re-radiate both the insonify- 
scanner transducer 40 also instills ultrasonic energy into the 
frequency is different than that of the insonifier. The inter- 3o increases 
section Of the two beams Of form an 
intersection volume which, in this example corresponds to a 
that are used in medical applications are 1.0 MHz to 5.0 
ing and the Scanner frequencies, but in addition they gen- 
when the insonifying frequency is 
near the microsphere resonant frequency. FIG. 3 shows that 
for Albunex, the effect peaks markedly at about Mhz 
4, if the Scanner probe 40 instills f2 at MHz and the 
patient's chest l5 at a sing1e frequency, but the Scanner erate non-linear difference and sum frequencies, This effect 
portion Of the myocardium 98. scanner frequencies which is the Albunex resonant frequency. Referring to FIG. 
MHz, but Other frequencies may be used. The limit On 35 insonifying transducer 10 instills f2 at 1.3 MHz, the sum 
the frequency is the attenuation Of the amp1itude Of the (fl+f2) and difference (f,-f, frequencies generated by the 
insonifying signal and the requirement that the frequency microspheres would be 3.3 MHz and 0.7 MHz, respectively. 
approximately match a resonant frequency Of the micro- Myocardial tissue, on the other hand, reflects the Scanner 
spheres. For for to the and insonifying frequencies but does not generate significant 
important factor for the insonifying frequency, frequencies 
ranging to 30 Mhz be used. The Scanner 40 
such that attenuation of the ultrasonic wave is not an 4o sum or difference frequencies, Myocardial generation of 
significant sum and difference frequencies would occur only 
i[ the insonifying frequency were near the myocardium 
also receives and processes the ultrasonic echo and gener- 
ates a video image. The received image is used to locate a 
frequency, 
To determine the concentration of the microspheres, con- 
region Of interest to evaluate myocardial perfusion by 
Of the microsphere detection method Of the present 
45 sider two intersecting beams, one with a frequency f, and the 
other with frequency f,, as illustrated in FIG, 4. The purpose 
of the measurement is to determine at any instant the tion. 
Although the present invention is illustrated in reference 
to circulation dynamics Of artend blood flow in myocardial 
concentration of microspheres in the insonified region, 
which is defined geometrically by the volume intersection or 
tissue, this apparatus and mcthod has broader application to 50 interaction volume of the two beams. Each microsphere in 
body Organ, body tissue Or  body fluid where alteration the interaction volume will respond by generating the mix- 
in fluid Or tissue dynamics is central to the Pathology under ing components of the two frequencies, f, and f2 (f,+f,, 
investigation. For example, with the use of suitable micro- fl-f2, zf,, 2f,, and to a lesser extent, 3f,, 3f2, and other 
spheres, the present invention Can be used to monitor blood non-linear products). n e  magnitude of the received signal 
flow patterns in the brain Of stroke patients, tumors, rCtina1 55 of each mixing component depends upon A,, the amplitude 
blood flow in the eye, tissues affected by pressure ulcers, and of f,, A,, the amplitude of f,, the total number of micro- 
blood Perfusion of tissue in P a  ofthe human body, spheres in the insonified region, and the microsphere mixing 
including muscle and tendon tissue. Additionally, the inven- efficiency, which depends upon microsphere properties (e,g,, 
tion can be used to enhance images of fluids and tissue in any resonance) and acoustic wavelengths, amplitudes, frequen- 
part of the body. The beat frequency signal image Can be 60 cies and phase relationships. 
superimposed on conventional scanning images to reveal With known drive amplitudes A, and A,, one can use a 
anatomy not otherwise visible to clinicians. direct measurement with a calibrated (receive) transducer 
The interface electronics consist of a mixer 50, two and knowledge of the tissue attenuations in the respective 
lowpass filters 70 and 72, a signal amplifier 80, and a lock-in insonifying beam paths to determine the concentration of 
amplifier 90. When microspheres 95 are injected into the 65 microspheres in the interaction volume. One way is to 
patient and reach the myocardium 98, the signal duc to the develop a tissue phantom which is placed between the drive 
microspheres 95 in the myocardial region of interest is transducers and the difference frequency sensing device. 
5,601,086 
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When the drive transducers are activated with specific drive 
wavcforms, thc calibration is made from measurements of 
thc mixcd frcquencies from a known concentration of micro- 
sphcrcs in thc interaction volume. With a determination of 
thc sizc of thc insonified volume in the patient, the only s 
unknown is the actual microsphere concentration, which 
therefore can be calculated from measurement and compari- 
son with the calibration results. The larger the amplitude of 
the in, sonifying waves, the greater is the amplitude of the 
detected wave and therefore the quicker the scan that can be IO 
performed. 
Thc frequcncy fl-f2 would be the lowest frequency com- 
ponent, and hence it would most likely be the most easily 
reccivcd of thc mixing components, since it would be the 
least aec ted  by tissue attenuation. Therefore, it will be used 1s 
to illustrate thc present invention, although any mixing 
component could be used. Once the difference frequency is 
gcncratcd, it must traverse the tissue between the generating 
microsphere and the transducer or transducer array. The 
output from this transducer is analyzed to determine micro- 20 
sphcre concentration. This analysis can be done by computer 
algorithm or other analytical means. The microspheres in the 
interaction volume of the two ultrasonic waves, each wave 
at its respective drive frequency, will be appropriately acti- 
The frequencies f, and f2 are chosen (1) so that either f, 
or f2 approximates the resonant frequency of the micro- 
spheres but differs from the resonant frequency of the tissue 
to bc examined and (2) so that the output of the difference 
frequency receiver transducer is maximized. Other consid- 30 
erations which affect the decision are tissue attenuation to fi 
and f2, distance of activation volume from the f, and f2 drive 
transducers, location of the difference frequency transducer, 
and the efficiency of microsphere generation of the differ- 
For example, if one is examining a region near the 
junction of muscle fibers to the tendon which attaches the 
muscle to the bone, the drive transducers could be spaced 
60" apart on the arc of a circle where the area under 
cxamination is located at the center. The receiver transducer, 40 
sensitive to the difference frequency fl-f2, can be placed on 
the same circle but located 150" from either insonifying 
transducer. Under these conditions, the ultrasonic waves 
generated by the insonifying transducers intersect at the area 
in question and the wave of frequency f,-f 
microspheres will propagate from the insonified volume at 
the center of the circle to the receive transducer. The output 
of the receive transducer is then proportional to the concen- 
tration of microspheres within the insonified volume. 
transducer is chosen to optimize the sensitivity to the drive 
frequcncy. The order of importance in selecting the drive 
frcquencies will be largely determined by the particular 
application. For example, if the region to be examined is 
approximately 5 cm deep and the receive transducer is 55 
placed directly below the area of examination, the following 
factors will be important in selecting the drive frequencies: 
(I)  the efficicncy of mixing of the two insonifying ultrasonic 
waves by the microspheres, (2) the attenuation of neighbor- 
ing tissue through which the insonifying ultrasonic waves 60 
must pass to reach the interaction volume, (3) the depth of 
thc interaction volume from the drive transducers, and (4) an 
acccptablc sitc location for the receive transducer. 
A high-gain, extremely narrow-band amplifier circuit 90 
(lock-in amplifier) detects precisely the difference frequency 65 
gcneratcd by the microsphercs 95. It does this by comparing 
the incoming RF signal to an exact difference reference 
vated. 25 
cncc frequency fl-f2. 35 
enerated by the 45 g. 
After the selection of the drive frequencies, the receive 50 
signal derived from electronically mixing the scanner trans- 
mit frequency and the chest insonifying frequency and 
lowpass filtering the result. The incoming RF echo signal 
contains both the myocardial tissue signal and the micro- 
sphere-generated signal consisting of the scanner, insonify- 
ing, sum and difference signals. The incoming RF echo 
signal also contains noise. A lowpass filter 72 is used to 
allow passage of only the difference frequency and the low 
frequency component of the noise to the lock-in amplifier 
circuit input. The lock-in amplifier circuit function can be 
understood by the following: 
Let: 
Acos(X)=electronically-generated difference signal (ref- 
erence signal) 
[Bcos(Y)+n(t)]=microsphere-generated difference signal 
(desired signal) plus noise, which constitutes the low- 
pass filtered incoming RF signal. 
The lock-in circuit 90 first electronically mixes the low- 
pass filtered incoming RF signal with the reference 
signal: 
Acos(X)[BCos(Y)+n(t)]=MBCos(X+Y)+YdBCos (X-Y) +n(t)A- 
c o s m  
If X=Y, then: 
Lowpass filtering the result gives: 
=%AB 
Le., a DC value which is proportional to the amplitudes of 
the reference signal and the desired microsphere signal. 
If the reference amplitude is held constant, then the result 
is a DC value proportional to only the microsphere-gener- 
ated difference signal. The lock-in amplifier circuit 90 can 
detect the microsphere signal even when the incoming RF 
signal is highly contaminated with noise of much greater 
amplitude. The lock-in function can be accomplished by 
either analog or digital (i.e., software) means. The output of 
the lock-in amplifier 90 consists of the amplitude of the 
microsphere difference frequency detected. Detection of the 
signal due to the microspheres is thus possible even at very 
low concentrations such as in the myocardium after periph- 
eral intravenous injection. 
Referring to FIG. 5, only a portion of the RF sector scan 
lines is analyzed, corresponding to the region of interest in 
the myocardium. Peaks corresponding to the transducer 
burst 120, anterior wall echo 130, and the posterior wall 
echo 140 are present in both scans. However, only the scan 
in which the contrast agent is present indicates microsphere 
RF echos 150. 
Refemng to FIG. 6, since f, and f2 are relatively close to 
each other, it is possible to use a single transducer 110. The 
intersection volume here is a cylinder 105 coaxially located 
beneath a single drive transducer. For this application it is 
possible to form an electrical drive signal by employing a 
summing circuit 60 to electrically add two electrical sine 
waves of different frequencies (f,, f2) together to form the 
electrical drive voltage. 
Although the present invention has been illustrated with 
reference to human applications, it should be understood by 
those skilled in the art of ultrasonic imaging that the present 
invention could also be used in a variety of applications in 
which the ultrasonic detection of fluids is contemplated. For 
example, the present invention could be used in animals, 
plant systems and in a variety of industrial flow processes. 
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Many modifications, improvements and substitutions will 
be apparent to the skilled artisan in view of the foregoing 
description without departing from the spirit and scope of 
the present invention as described in the specification and 
defined in the following claims. Thus, it is to be understood 5 
that, within the scope of the appended claims, the invention 
may be practiced other than as spccifically described here- 
inabove. is a receive transducer. 
means for detecting the sum and difference frequencies. 
6. The apparatus of claim 5 wherein the directing means 
for the ultrasonic energy at the first frequency is a transducer. 
7. The apparatus of claim 6 wherein the directing means 
for the ultrasonic energy at the second frequency is a 
kimducer. 
8. The apparatus of claim 7 wherein the detecting means 
What is claimed is: 9. An method for detecting the presence of ultrasonically 
1, An apparatus for detecting the presence of ultrasoni- 10 reflCCtiVe microsphere Contrast agents in a fluid, comprising: 
cally relative microsphere contrast agents in a fluid, com- directing ultrasonic energy into a region of the fluid at a 
prising: first frequency, the first discrete frequency being 
means for directing ultrasonic energy into a region of the approximately at a resonant frequency of the micro- 
fluid at a first discrete frequency, the first frequency spheres in the range of 1 MHz-30 MHz; 
being approximately at a resonant frequency of the 15 simultaneously directing ultrasonic energy in to the region 
microspheres in the range of 1 MHz-30 MHz; of fluid at a second discrete frequency that is also an 
means for simultaneously directing ultrasonic energy into approximate resonant frequency of the microspheres, 
the region of fluid at a second discrete frequency that is wherein the microspheres in the fluid interact to emit 
also an approximate resonant frequency of the micro- sum and difference frequencies; and 
spheres, wherein the microspheres in the fluid interact 2o 
to emit sum and difference frequencies; and 
detecting the sum and difference frequencies. 
10. A method for detecting the presence of ultrasonically 
reflective microsphere contrast agents in a body fluid, com- 
prising the steps of: 
injecting microbubble contrast agents into a living body; 
directing ultrasonic energy into a region of the body fluid 
at a first discrete frequency, the first frequency being 
approximately at a resonant frequency of the micro- 
spheres in the range of 1 MHz-30 MHz; 
simultaneously directing ultrasonic energy into the body 
fluid region at a second discrete frequency that is also 
an approximate resonant frequency of the micro- 
spheres, such that the microspheres interact to emit sum 
and difference freauencies: and 
means for detecting the sum and difference frequencies. 
2. The apparatus of claim 1 wherein the directing means 
for the ultrasonic energy at the first frequency is a transducer. 25 
3. The apparatus of claim 2 wherein the directing means 
for the ultrasonic energy at the second frequency is a 
transducer. 
4. The apparatus of claim 3 wherein the detecting means 
is a receive transducer. 
5. An apparatus for measuring the presence of ultrasoni- 
cally reflective microsphere contrast agents in a living body 
fluid, comprising: 
means for injecting microbubble contrast agents into a 
means for directing ultrasonic cnergy into a region of the 
body fluid at a first discrete frequency, the first fre- 
quency being approximately at a resonant frequency of 
the microspheres in the range of 1 MHz-30 MHz; 
means for simultaneously directing ultrasonic energy into 40 
the region of body fluid at a second discrete frequency 
that is also an approximate resonant frequency of the 
microspheres, wherein the microspheres interact to 
emit sum and difference frequencies; and 
30 
living body; 35 detecting the mixed frequencies generated by interaction 
of the resonant microspheres with ultrasonic energy at 
the first and second frequencies. 
11. A method for detecting the presence of ultrasonically 
reflective microsphere contrast agents in a body fluid as in 
claim 10 wherein said means for injecting microbubble 
contrast agents further comprise a means for injecting albu- 
min-coated microbubble contrast agents. 
* * * * *  
